Search results
Company News for June 5, 2024
Zacks via Yahoo Finance· 3 days agoHealthEquity, Inc. (HQY) rose 2.7% after reporting first-quarter adjusted earnings per share of $0.80, surpassing the Zacks Consensus Estimate of $0.66...
IAS ANNOUNCES INDUSTRY-FIRST DEEPFAKE MEASUREMENT CAPABILITIES
StreetInsider· 4 days agoInnovation Builds Upon IAS's AI-Driven Misinformation Reporting To Safeguard Brands Ahead of U.S....
Lenders Sue Equifax Alleging Antitrust Violations
National Mortgage Professional· 5 days agoEquifax, one of the largest consumer credit reporting agencies among “The Big Three” of itself, Experian, and TransUnion, must contend with antitrust...
Oracle $16 Billion VA Health Software Scores Badly in Internal Report
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Oracle Corp.’s most high-profile medical records customer, the US Department of...
Argan Inc (AGX) Q1 FY2025 Earnings: EPS and Revenue Beat Expecta
Guru Focus· 2 days agoRevenue: $157.7 million, up by 52.1% year-over-year, surpassing estimates of $134.75 million.Net Income: $7.9 million, a significant increase from $2.1 million
Fresenius lifts 2024 targets for private healthcare unit Helios
Reuters· 3 days ago, opens new tab raised the yearly guidance for its private healthcare provider Helios on Wednesday, following a strong start to 2024 and the conclusion of group-wide restructuring. The Hessian-based ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters· 1 day ago, opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after...
Short on curbside chargers, New York EV drivers are improvising
Detroit News· 5 days agoPrompted to describe the issue, she answers with voice-to-text: “Gas car parking at electric vehicle...
Three TSX Growth Companies With At Least 10% Insider Ownership
Simply Wall St. via Yahoo Finance· 5 days agoOver the past week, Canada's market has shown stability with no significant changes, while it has...
10 Highest-Priced Stocks Right Now
AOL· 4 days ago"Expensive" is a relative term when discussing the stock market. Many investors measure a share's cost by the stock's price relative to its earnings or sales. Check Out: 4 Genius Things All Wealthy...
